Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1537072

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1537072

Mesotherapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Persistence Market Research has recently released a comprehensive report on the global mesotherapy market. The report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Mesotherapy Market Size (2024E): USD 513.6154 million
  • Projected Market Value (2033F): USD 1501.1 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 12.7%

Mesotherapy Market - Report Scope:

Mesotherapy involves delivering a series of microinjections of vitamins, enzymes, hormones, and plant extracts into the mesoderm layer of the skin to rejuvenate and tighten skin, as well as to reduce fat. This minimally invasive cosmetic procedure is primarily used for skin rejuvenation, body contouring, and reducing localized fat deposits. The mesotherapy market caters to clinics, dermatology centers, and cosmetic surgery centers, offering a range of treatment options and products, including injectables and non-invasive devices. Market growth is driven by increasing demand for non-surgical cosmetic procedures, rising awareness about mesotherapy benefits, and advancements in injection technologies, enhancing treatment outcomes and patient satisfaction.

Market Growth Drivers:

The global mesotherapy market is propelled by several key factors, including a growing preference for non-invasive cosmetic procedures as an alternative to surgical interventions. The increasing incidence of skin aging, localized fat accumulation, and other aesthetic concerns among both men and women contributes to the demand for mesotherapy treatments. Technological advancements in injection devices and formulations, such as the development of advanced mesotherapy injectables and combination therapies, further drive market expansion. Additionally, rising disposable incomes, greater access to cosmetic services, and the influence of social media and celebrity endorsements boost market growth and consumer interest.

Market Restraints:

Despite promising growth prospects, the mesotherapy market faces challenges related to safety concerns, regulatory issues, and high treatment costs. Potential side effects, such as bruising, swelling, and allergic reactions, pose risks that may deter potential patients. Regulatory hurdles related to the approval and standardization of mesotherapy products and procedures impact market entry and operational costs. Moreover, the high cost of mesotherapy treatments and the lack of insurance coverage can limit accessibility and market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these issues requires industry stakeholders to enhance safety protocols, advocate for regulatory clarity, and explore cost-effective treatment options.

Market Opportunities:

The mesotherapy market presents significant growth opportunities driven by technological innovations, evolving consumer preferences, and expanding application areas. The integration of advanced technologies, such as needle-free mesotherapy systems and personalized treatment protocols, enhances treatment efficacy and patient comfort. Furthermore, the growing trend of preventive aesthetic treatments and the expansion of mesotherapy applications beyond traditional uses, such as in hair restoration and cellulite reduction, broaden market potential. Strategic partnerships, investment in research and development, and the introduction of innovative mesotherapy solutions are crucial to capitalizing on emerging opportunities and sustaining market leadership in the dynamic mesotherapy landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the mesotherapy market globally?
  • Which mesotherapy applications and treatment types are driving adoption across different healthcare settings?
  • How are technological advancements influencing the competitive landscape of the mesotherapy market?
  • Who are the key players contributing to the mesotherapy market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global mesotherapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global mesotherapy market, including Allergan plc, Galderma S.A., and Revance Therapeutics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced mesotherapy solutions, including new injectables, needle-free systems, and combination therapies, catering to diverse patient needs and clinical requirements. Collaborations with cosmetic clinics, dermatologists, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving mesotherapy landscape.

Key Companies Profiled:

  • Laboratories FILORGO SA
  • INSTITUTE BCN
  • mesoskinline
  • Koru Pharmaceuticals Co., Ltd.
  • Fusion Meso
  • TOSKANI COSMETICS
  • Dr. Korman Laboratories Ltd.
  • Ostar Beauty Sci-Tech Co Ltd.
  • Aemesso U.S.A. Corp
  • Perse Belle
  • Dermo Aroma
  • Pluryal
  • Messoessence
  • Novaderm
  • Dermaqual
  • Allergan
  • Maypharm
  • Galderma Laboratories

Key Segments Covered in Mesotherapy Industry Research

Product:

  • Mesotherapy Fillers Kits
  • Mesotherapy Solutions Kits
  • Mesotherapy Chemical Peels
  • Anti-ageing Masks
  • Mesotherapy Creams
  • Mesotherapy Spray

Indication:

  • Anti-ageing
  • Facial Rejuvenation
  • Wrinkle Treatment
  • Stretch marks
  • Acne & Scar Treatment
  • Fat Loss
  • Hair Loss/Alopecia

Distribution Channel:

  • Hospitals
  • Dermatology Clinics
  • Cosmetic Clinics
  • Online Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa
Product Code: PMRREP30409

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - Key Statistics
  • 4.2. Value Chain Analysis
  • 4.3. Key Regulations - By Region
  • 4.4. Product USP Analysis
  • 4.5. Recent Product Approvals
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Dermatology Market Outlook
  • 5.2. Forecast Factors - Relevance and Impact
    • 5.2.1. Increasing Prevalence of Skin Disease
    • 5.2.2. Rising Prevalence of Skincare
    • 5.2.3. Increased Mergers and Acquisitions
    • 5.2.4. Innovation and Development
    • 5.2.5. New Advancements in Treatment
    • 5.2.6. Regulatory Approvals
    • 5.2.7. Research and Development for New Drugs
    • 5.2.8. Technological Advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
    • 10.3.1. Mesotherapy Fillers Kits
    • 10.3.2. Mesotherapy Solutions Kits
    • 10.3.3. Mesotherapy Chemical Peels
    • 10.3.4. Anti-ageing Masks
    • 10.3.5. Mesotherapy Creams
    • 10.3.6. Mesotherapy Spray
      • 10.3.6.1. Mesotherapy Devices
      • 10.3.6.2. Microneedling Pens
      • 10.3.6.3. Dermarollers
      • 10.3.6.4. Injection Guns
      • 10.3.6.5. Mesotherapy Needles and Cannulas
      • 10.3.6.6. Skin Analyzers
  • 10.4. Market Attractiveness Analysis, By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024-2033
    • 11.3.1. Anti-ageing
    • 11.3.2. Facial Rejuvenation
    • 11.3.3. Wrinkle Treatment
    • 11.3.4. Stretch marks
    • 11.3.5. Acne and Scar Treatment
    • 11.3.6. Fat Loss
    • 11.3.7. Hair Loss/Alopecia
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis, By Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Dermatology Clinics
    • 12.3.3. Cosmetic Clinics
    • 12.3.4. Online Sales
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis and Forecast
    • 14.8.1. U.S. Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Canada Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channel

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis and Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channel

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis and Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By Distribution Channel
    • 16.8.5. Spain Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By Distribution Channel
    • 16.8.6. BENELUX Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By Distribution Channel
    • 16.8.7. Russia Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By Distribution Channel

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Product
    • 17.4.2. By Indication
    • 17.4.3. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis and Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channel
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By Distribution Channel

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis and Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channel

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By Distribution Channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis and Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By Distribution Channel
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Product
    • 20.4.2. By Indication
    • 20.4.3. By Distribution Channel
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis and Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By Distribution Channel
    • 20.8.2. Turkiye Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By Distribution Channel
    • 20.8.3. South Africa Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By Distribution Channel
    • 20.8.4. North Africa Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By Distribution Channel

21. Market Structure Analysis

  • 21.1. Market Analysis, by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. By Regional Footprints of Players
    • 21.4.2. By Product Footprints of Players
    • 21.4.3. By Channel Footprints of Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Laboratoires FILORGA SA
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Sales Footprint
      • 22.2.1.4. Key Financials
      • 22.2.1.5. SWOT Analysis
      • 22.2.1.6. Strategy Overview
        • 22.2.1.6.1. Marketing Strategy
        • 22.2.1.6.2. Product Strategy
        • 22.2.1.6.3. Channel Strategy
    • 22.2.2. INSTITUTE BCN
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Sales Footprint
      • 22.2.2.4. Key Financials
      • 22.2.2.5. SWOT Analysis
      • 22.2.2.6. Strategy Overview
        • 22.2.2.6.1. Marketing Strategy
        • 22.2.2.6.2. Product Strategy
        • 22.2.2.6.3. Channel Strategy
    • 22.2.3. Mesoskinline
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Sales Footprint
      • 22.2.3.4. Key Financials
      • 22.2.3.5. SWOT Analysis
      • 22.2.3.6. Strategy Overview
        • 22.2.3.6.1. Marketing Strategy
        • 22.2.3.6.2. Product Strategy
        • 22.2.3.6.3. Channel Strategy
    • 22.2.4. Koru Pharmaceuticals Co., Ltd.
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Sales Footprint
      • 22.2.4.4. Key Financials
      • 22.2.4.5. SWOT Analysis
      • 22.2.4.6. Strategy Overview
        • 22.2.4.6.1. Marketing Strategy
        • 22.2.4.6.2. Product Strategy
        • 22.2.4.6.3. Channel Strategy
    • 22.2.5. Fusion Meso
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Sales Footprint
      • 22.2.5.4. Key Financials
      • 22.2.5.5. SWOT Analysis
      • 22.2.5.6. Strategy Overview
        • 22.2.5.6.1. Marketing Strategy
        • 22.2.5.6.2. Product Strategy
        • 22.2.5.6.3. Channel Strategy
    • 22.2.6. TOSKANI COSMETICS
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Sales Footprint
      • 22.2.6.4. Key Financials
      • 22.2.6.5. SWOT Analysis
      • 22.2.6.6. Strategy Overview
        • 22.2.6.6.1. Marketing Strategy
        • 22.2.6.6.2. Product Strategy
        • 22.2.6.6.3. Channel Strategy
    • 22.2.7. Dr. Korman Laboratories Ltd.
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Sales Footprint
      • 22.2.7.4. Key Financials
      • 22.2.7.5. SWOT Analysis
      • 22.2.7.6. Strategy Overview
        • 22.2.7.6.1. Marketing Strategy
        • 22.2.7.6.2. Product Strategy
        • 22.2.7.6.3. Channel Strategy
    • 22.2.8. Ostar Beauty Sci-Tech Co Ltd.
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Sales Footprint
      • 22.2.8.4. Key Financials
      • 22.2.8.5. SWOT Analysis
      • 22.2.8.6. Strategy Overview
        • 22.2.8.6.1. Marketing Strategy
        • 22.2.8.6.2. Product Strategy
        • 22.2.8.6.3. Channel Strategy
    • 22.2.9. Aemesso U.S.A. Corp
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Sales Footprint
      • 22.2.9.4. Key Financials
      • 22.2.9.5. SWOT Analysis
      • 22.2.9.6. Strategy Overview
        • 22.2.9.6.1. Marketing Strategy
        • 22.2.9.6.2. Product Strategy
        • 22.2.9.6.3. Channel Strategy
    • 22.2.10. Perse Belle
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Sales Footprint
      • 22.2.10.4. Key Financials
      • 22.2.10.5. SWOT Analysis
      • 22.2.10.6. Strategy Overview
        • 22.2.10.6.1. Marketing Strategy
        • 22.2.10.6.2. Product Strategy
        • 22.2.10.6.3. Channel Strategy
    • 22.2.11. Dermo Aroma
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Sales Footprint
      • 22.2.11.4. Key Financials
      • 22.2.11.5. SWOT Analysis
      • 22.2.11.6. Strategy Overview
        • 22.2.11.6.1. Marketing Strategy
        • 22.2.11.6.2. Product Strategy
        • 22.2.11.6.3. Channel Strategy
    • 22.2.12. Pluryal
      • 22.2.12.1. Overview
      • 22.2.12.2. Product Portfolio
      • 22.2.12.3. Sales Footprint
      • 22.2.12.4. Key Financials
      • 22.2.12.5. SWOT Analysis
      • 22.2.12.6. Strategy Overview
        • 22.2.12.6.1. Marketing Strategy
        • 22.2.12.6.2. Product Strategy
        • 22.2.12.6.3. Channel Strategy
    • 22.2.13. Messoessence
      • 22.2.13.1. Overview
      • 22.2.13.2. Product Portfolio
      • 22.2.13.3. Sales Footprint
      • 22.2.13.4. Key Financials
      • 22.2.13.5. SWOT Analysis
      • 22.2.13.6. Strategy Overview
        • 22.2.13.6.1. Marketing Strategy
        • 22.2.13.6.2. Product Strategy
        • 22.2.13.6.3. Channel Strategy
    • 22.2.14. Novaderm
      • 22.2.14.1. Overview
      • 22.2.14.2. Product Portfolio
      • 22.2.14.3. Sales Footprint
      • 22.2.14.4. Key Financials
      • 22.2.14.5. SWOT Analysis
      • 22.2.14.6. Strategy Overview
        • 22.2.14.6.1. Marketing Strategy
        • 22.2.14.6.2. Product Strategy
        • 22.2.14.6.3. Channel Strategy
    • 22.2.15. Dermaqual
      • 22.2.15.1. Overview
      • 22.2.15.2. Product Portfolio
      • 22.2.15.3. Sales Footprint
      • 22.2.15.4. Key Financials
      • 22.2.15.5. SWOT Analysis
      • 22.2.15.6. Strategy Overview
        • 22.2.15.6.1. Marketing Strategy
        • 22.2.15.6.2. Product Strategy
        • 22.2.15.6.3. Channel Strategy
    • 22.2.16. Allergan
      • 22.2.16.1. Overview
      • 22.2.16.2. Product Portfolio
      • 22.2.16.3. Sales Footprint
      • 22.2.16.4. Key Financials
      • 22.2.16.5. SWOT Analysis
      • 22.2.16.6. Strategy Overview
        • 22.2.16.6.1. Marketing Strategy
        • 22.2.16.6.2. Product Strategy
        • 22.2.16.6.3. Channel Strategy
    • 22.2.17. Maypharm
      • 22.2.17.1. Overview
      • 22.2.17.2. Product Portfolio
      • 22.2.17.3. Sales Footprint
      • 22.2.17.4. Key Financials
      • 22.2.17.5. SWOT Analysis
      • 22.2.17.6. Strategy Overview
        • 22.2.17.6.1. Marketing Strategy
        • 22.2.17.6.2. Product Strategy
        • 22.2.17.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!